Flexagen Joint Care "From The Makers of Advil " Hitting Shelves Now
This article was originally published in The Tan Sheet
Executive Summary
Flexagen, a glucosamine/chondroitin joint care supplement, will be backed by a national TV and print ad campaign breaking in July, Whitehall-Robins announced at the National Association of Chain Drug Stores Marketplace in New Orleans June 25-28.
You may also be interested in...
Hauser Non-Botanical Supplement Deal Could Help Offset Herbal Declines
A new collaboration with Whitehall-Robins to develop a non-botanical dietary supplement could help Hauser overcome recent losses stemming from a decline in the natural ingredient supplier's herbal business.
Weider's Schiff Move Free FY 2000 Sales Jump 55% To $110 Mil.
Schiff Move Free glucosamine/chondroitin sales spiked 55% to approximately $110 mil. for the fiscal year ended May 31, Weider President and CEO Bruce Wood told analysts during a conference call Aug. 18.
Perrigo
Ibuprofen Migraine Pain (Motrin Migraine Pain), cromolyn sodium nasal spray (Nasalcrom) and ibuprofen cold & sinus (Advil Cold & Sinus) are among the private-label products in the pipeline; however, the granting of pediatric exclusivity could set back their launch. Upcoming supplements from Perrigo include MSM with glucosamine, bone & joint gelatin powder (NutraJoint), calcium 600 + soy, a multivitamin with lutein, FreeFlex glucosamine (Aflexa) and two glucosamine/chondroitin products (Flexagen and Osteo-Bi-Flex) (1see related story, p. 14)